Genetic loci for Skin Fluorescence in type 1 Diabetes Mellitus

Withdrawn

• Conditions: identificeren van SNPs die geassocieerd zijn met huid fluorescentie; single nucleotide polymorphism; snip; 10012653

• Registration Number: NL-OMON42373
• Lead Sponsor: Medisch Centrum Alkmaar

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Withdrawn
• Sex: Not specified
• Target Recruitment: 350

Inclusion Criteria

Signed informed consent
Type 1 DM
Age * 18 years

Exclusion Criteria

Subjects who lack mental capacity to make their own decision / subjects who have a legal-guardian for ongoing medical decisions (including but not limited to mental retardation, schizophrenia, bi-polar disorder, degenerative cognitive decline). ;Participant in life-line study.

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The primary outcome variable for the Genomic-Wide Association Study (GWAS) will<br /><br>be Skin Auto Fluorescence (SAF). </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Association of SNPs with HbA1c</p><br>